Research into most effective cancer treatments presented at breast cancer symposium

Press/Media: Research

Period10 Dec 2012

Media coverage

24

Media coverage

  • TitleExtending time provided no additional benefit for patients with HER2-positive breast cancer
    Degree of recognitionInternational
    Media name/outletMedIndia online
    Media typeWeb
    Date12/12/12
    PersonsDavid Cameron
  • TitleInstitut de cancer: plus de candidat
    Degree of recognitionInternational
    Media name/outletLe Dépêche du Midi
    Date11/12/12
    PersonsDavid Cameron
  • TitleMore bad news for Avastin in breast cancer
    Degree of recognitionInternational
    Media name/outletMedPage Today
    Date11/12/12
    PersonsDavid Cameron
  • Title5 new breast cancer discoveries
    Degree of recognitionInternational
    Media name/outletCNN Wire (USA)
    Date10/12/12
    PersonsDavid Cameron
  • Title5 new breast cancer discoveries
    Degree of recognitionInternational
    Media name/outletWTVR.com (USA)
    Media typeTelevision
    Date10/12/12
    PersonsDavid Cameron
  • Title5 new breast cancer discoveries
    Degree of recognitionInternational
    Media name/outletWTKR-TV online (USA)
    Media typeTelevision
    Date10/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletTopanga Messenger
    Date10/12/12
    PersonsDavid Cameron
  • TitleDoes BEATRICE spell the end of bevacizumab in breast cancer?
    Degree of recognitionInternational
    Media name/outletTopanga Messenger
    Date8/12/12
    PersonsDavid Cameron
  • TitleAdjuvant bevacizumab falls short in triple-negative breast cancer
    Degree of recognitionInternational
    Media name/outletOncLive online (USA)
    Media typeWeb
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletKLFY
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletWBOC TV 16
    Media typeTelevision
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletWTen online
    Media typeWeb
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletMedBroadcast
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletNewsChannel10 (KFDA)
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletKCEN TV NBC 6
    Media typeTelevision
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletNational Women's Health Information Center
    Date8/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outlet13WHAM.com
    Date7/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletWECT TV-6
    Media typeTelevision
    Date7/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletWLNS
    Date7/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletHealth Day online (USA)
    Media typeWeb
    Date7/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletMedical Express online
    Media typeWeb
    Date7/12/12
    PersonsDavid Cameron
  • TitleAvastin won't extend breast cancer survival
    Degree of recognitionInternational
    Media name/outletCBS 3 Springfield online (USA)
    Media typeWeb
    Date7/12/12
    PersonsDavid Cameron
  • TitleAdjuvant bevacizumab did not improve invasive disease-free survival in triple-negative breast cancer
    Degree of recognitionInternational
    Media name/outletAmerican Association for Cancer Research
    Date7/12/12
    PersonsDavid Cameron
  • TitleAvastin no prolonga la supervivencia del cancer de mama
    Degree of recognitionInternational
    Media name/outletSalud y Bienestar online (Spain)
    Media typeWeb
    Date7/12/12
    PersonsDavid Cameron